Studies show college athletes sleeping less than 7 hours per night are almost twice as likely to be injured when compared with athletes sleeping more than 8 hours.
Articles on Alzheimer's disease
Displaying 121 - 140 of 448 articles
Two thirds of people with Alzheimer’s disease are women – but activation of a brain protein called CYP46A1 might hold the key to prevention.
Montréal is home to one of the world’s largest brain banks, the Douglas-Bell Canada Brain Bank, where discoveries about different neurological and psychiatric diseases are made.
How to have honest, open conversations with your partner about dementia.
Lifestyle-related dementia risks are complex, with factors like sleep, exercise, diet and social contact interacting with things like cognitive reserve, neuroplasticity and inflammation in the body.
This study shows at least two different mechanisms lead to cognitive decline – both in healthy people and people with Alzheimer’s.
The NHS will trial a new blood test for dementia, which could be widely available in five years.
Does being bilingual protect against Alzheimer’s? Can it help slow cognitive decline? There is clear evidence that it causes beneficial and long-lasting changes in the brain.
A recent study from Sweden found people with a history of chronic stress or depression had a heightened risk of developing Alzheimer’s disease.
Dementia does not manifest solely as a memory problem. People with dementia can also experience issues with learning, comprehension and judgement, but they may also experience changes in behaviour.
It’s long been known that exercise helps maintain strength and agility as we age. New research points to the importance of exercise type in supporting cognitive health in the latest decades of life.
Fish oil has been promised to provide all sorts of health benefits – from boosting our heart health, protecting our brain and easing arthritis. Here’s how the claims stack up for fish and supplements.
These blood tests results need care when interpreting, and they can not they predict how the disease will affect each person.
Despite decades of starts and stops, new treatments and key genetic discoveries are giving researchers great hope for slowing or eventually preventing Alzheimer’s disease.
Several new drugs have recently been approved in the US to treat Alzheimer’s disease. But they’re not quite the breakthrough that some are claiming.
Disorders such as Alzheimer’s and epilepsy are difficult to diagnose with only occasional doctor visits. A new approach would allow fathering of extensive real-world data directly from patients.
Humans have attempted to understand and treat mental illness for centuries – from ancient Greek medicine, Middle Ages exorcisms and the rise of asylums, to modern medical breakthroughs.
While there is no guarantee of warding off cognitive decline, encouraging people to be physically, mentally and socially active could potentially keep a significant number of dementia cases at bay.
In the short-term, inflammation is a sign your body is healing. But persistent levels of inflammation in blood and tissue, called ‘inflammaging’, is linked to disease. Diet might help.
The drug has been hailed as a ‘turning point’ in Alzheimer’s treatment. But keep in mind the trial only included participants with early or mild disease. And while it slowed decline, it’s not a cure.
Top contributors
-
PhD Candidate, Neuroscience, University of Sheffield
-
Research Fellow in Neuroimmunology, UCL
-
Professor of Biological Psychology, Loughborough University
-
Professor of Chemistry and Senior Scientist of the Krembil Research Institute, University Health Network, University of Toronto
-
Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University
-
Professor Emeritus of Molecular Neurobiology at the University of Manchester and a Visiting Professorial Fellow, University of Oxford
-
Associate Professor, Turner Institute for Brain and Mental Health, Monash University
-
Professor of Neurology and Neuroscience, University of Florida
-
Host, The Conversation Weekly Podcast, The Conversation
-
Professor of Neurology, UCL
-
Post grad student at University of Edinburgh, University of Edinburgh
-
Associate Professor in Cellular Neuroscience, University of Reading
-
Professor of Psychology in Epidemiology, UCL
-
Étudiant au doctorat en psychologie, Université du Québec à Montréal (UQAM)
-
Affiliate Professor, Department of Family Medicine, McGill University